Caveolin-1 in tumor progression: the good, the bad and the ugly

被引:250
作者
Goetz, Jacky G. [1 ]
Lajoie, Patrick [1 ]
Wiseman, Sam M. [2 ,3 ]
Nabi, Ivan R. [1 ]
机构
[1] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada
[2] St Pauls Hosp, Dept Surg, Vancouver, BC V6Z 1Y6, Canada
[3] Univ British Columbia, Vancouver, BC V6Z 1Y6, Canada
关键词
Caveolin-1; cancer; tumor progression;
D O I
10.1007/s10555-008-9160-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Caveolin-1 (Cav1) is a multifunctional scaffolding protein with multiple binding partners that is associated with cell surface caveolae and the regulation of lipid raft domains. Cav1 regulates multiple cancer-associated processes including cellular transformation, tumor growth, cell migration and metastasis, cell death and survival, multidrug resistance and angiogenesis. However, Cav1 has been reported to impact both positively and negatively on various aspects of tumor progression and while reported to function as a tumor suppressor, it has also been identified as a poor prognostic factor in various human cancers. In this review, we survey the functional roles of Cav1 in cancer and argue that Cav1 function is interdependent on tumor stage and the expression of molecular effectors that impact on its role during tumor progression.
引用
收藏
页码:715 / 735
页数:21
相关论文
共 274 条
  • [21] Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma
    Campbell, L
    Gumbleton, M
    Griffiths, DFR
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1909 - 1913
  • [22] Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures
    Campbell, L
    Hollins, AJ
    Al-Eid, A
    Newman, GR
    von Ruhland, C
    Gumbleton, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (03) : 744 - 751
  • [23] Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling
    Cantiani, Lara
    Manara, Maria Cristina
    Zucchini, Cinzia
    De Sanctis, Paola
    Zuntini, Monia
    Valvassori, Luisa
    Serra, Massimo
    Olivero, Martina
    Di Renzo, Maria Flavia
    Colombo, Mario Paolo
    Picci, Piero
    Scotlandi, Katia
    [J]. CANCER RESEARCH, 2007, 67 (16) : 7675 - 7685
  • [24] A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14 - Recruitment of C-terminal Src kinase
    Cao, HM
    Courchesne, WE
    Mastick, CC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) : 8771 - 8774
  • [25] Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation
    Capozza, F
    Williams, TM
    Schubert, W
    McClain, S
    Bouzahzah, B
    Sotgia, F
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) : 2029 - 2039
  • [26] Caveolin expression in adult renal tumors
    Carrion, R
    Morgan, BE
    Tannenbaum, M
    Salup, R
    Morgan, MB
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (03) : 191 - 196
  • [27] Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: Concrete premises for a new reliable diagnostic marker in gliomas
    Cassoni, Paola
    Senetta, Rebecca
    Castellano, Isabella
    Ortolan, Erika
    Bosc, Martino
    Magnani, Ivana
    Ducati, Alessandro
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (05) : 760 - 769
  • [28] Senescent phenotype can be reversed by reduction of caveolin status
    Cho, KA
    Ryu, SJ
    Park, JS
    Jang, IS
    Ahn, JS
    Kim, KT
    Park, SC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (30) : 27789 - 27795
  • [29] Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue
    Cohen, AW
    Razani, B
    Wang, XB
    Combs, TP
    Williams, TM
    Scherer, PE
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 285 (01): : C222 - C235
  • [30] Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts
    Cohen, AW
    Park, DS
    Woodman, SE
    Williams, TM
    Chandra, M
    Shirani, J
    De Souza, AP
    Kitsis, RN
    Russell, RG
    Weiss, LM
    Tang, BY
    Jelicks, LA
    Factor, SM
    Shtutin, V
    Tanowitz, HB
    Lisanti, MP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02): : C457 - C474